| Product Name | MF | CAS | Details |
|---|
| 3-Hydroxyisonicotinaldehyde | C6H5NO2 | 1849-54-3 | Details |
| 2,3,6,7,10,11-Hexahydroxytriphenylene hydrate | C18H12O6 | 4877-80-9 | Details |
| 2-(5-(Difluoromethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C13H16BF3O2 | 1142228-23-6 | Details |
| 3-[1-(Methylamino)ethyl]benzene-1-sulfonamide | C9H14N2O2S | 1157112-20-3 | Details |
| Biotinyl-Asp-Glu-Val-Asp-aldehyde (pseudo acid) | C28H42N6O12S | 178603-73-1 | Details |
| 4,5-Dihydrothiophene-2-carboxylic acid | C5H6O2S | 86610-33-5 | Details |
| Phenyl(4H-1,2,4-triazol-3-yl)methanamine hydrochloride | C9H10N4.HCl | 1432680-52-8 | Details |
| 1-Phenyl-7-oxa-2-azaspiro[3.5]nonane | C13H17NO | 1909337-33-2 | Details |
| rac-(3aR,6aR)-Hexahydro-2H-1λ6-thieno[2,3-c]pyrrole-1,1-dione hydrochloride | C6H11NO2S.ClH | 1320326-61-1 | Details |
| Direct Blue 202 | 107043-92-5 | Details |
| Ribophorin I Blocking Peptide | Details |
| C1ORF43 Blocking Peptide | Details |
| 4-(2,2-Difluoroethoxy)-3-methoxybenzaldehyde oxime | C10H11F2NO3 | 1245782-75-5 | Details |
| ALOX15 antibody | Details |
| BORIS antibody | Details |
| Tasisulam sodium | C11H5BrCl2NNaO3S2 | 519055-63-1 | Details |
| Benzyl 1-oxa-5-azaspiro[2.5]octane-5-carboxylate | C14H17NO3 | 1047655-54-8 | Details |
| Sulbactam pivoxyl | C14H21NO7S | 69388-79-0 | Details |
| 3-(4-Ethylphenyl)pyrrolidine hydrochloride | C12H18ClN | 1803609-53-1 | Details |
| (2E)-1-(2-Hydroxyphenyl)-3-phenyl-2-propen-1-one | C15H12O2 | 888-12-0 | Details |
| 3-(Benzylamino)-4-methylpentanoic acid | C13H19NO2 | 118248-61-6 | Details |
| 2-(Piperidin-4-yloxy)quinoxaline | C13H15N3O | 1185538-34-4 | Details |
| N-Palmitoyl-D-sphingomyelin | C39H79N2O6P | 6254-89-3 | Details |
| 4-(o-Tolyl)piperidine | C12H17N | 630116-52-8 | Details |
| (E)-Coniferin | C16H22O8 | 124151-33-3 | Details |
| TTC6 Blocking Peptide | Details |
| Influenza A antibody (H1N1) (HRP) | Details |
| 2-[4-Amino-3-(trifluoromethyl)phenoxy]ethan-1-ol | C9H10F3NO2 | 1021024-20-3 | Details |
| 5-(Chloromethyl)-2-methoxypyridine | C7H8ClNO | 101990-70-9 | Details |
| 5-Methoxy-1-methyl-3-(propan-2-yl)-1H-pyrazole-4-carbaldehyde | C9H14N2O2 | 1258651-69-2 | Details |
| 2-(4-Chlorobenzyl)pyridine | C12H10ClN | 4350-41-8 | Details |
| o-Toluoyl-5-hydroxy omeprazole | C25H25N3O5S | 120003-79-4 | Details |
| Obtusilin | C30H46O4 | 105870-59-5 | Details |
| 2-(((4-fluorophenyl)amino)ethylidene)indane-1,3-dione | C17H12FNO2 | 59876-60-7 | Details |
| Diclofenac methyl ester | C15H13Cl2NO2 | 15307-78-5 | Details |
| 2,2,2-Trifluoroethyl N-[3-(furan-2-amido)phenyl]carbamate | C14H11F3N2O4 | 1223299-00-0 | Details |
| 5-Chloro-2-methylanisole | C8H9ClO | 40794-04-5 | Details |
| H-VSNK-OH | Details |
| Angiotensin IV (3-8) | Details |
| WKYMVdM TRIFLUOROACETATE | C43H62F3N9O9S2 | 1313730-09-4 | Details |
| 3-Cyano-5-hydroxy-4-methoxybenzoic acid | C9H7NO4 | 80547-68-8 | Details |
| RPA1 Blocking Peptide | Details |
| 2-(Benzyloxy)-3,3-dimethylcyclobutan-1-one | 2248327-30-0 | Details |
| Bix-02188 | C25H24N4O2 | 334949-59-6 | Details |
| 4-Methyltetrahydro-2H-pyran-4-carbaldehyde | C7H12O2 | 65626-22-4 | Details |
| (S)-(+)-2-Amino-3-methylbutane | C5H13N | 22526-46-1 | Details |
| 5-Bromovaleric acid methyl ester | C6H11BrO2 | 5454-83-1 | Details |
| Carrageenan | NULL | 9000-07-1 | Details |
| 2'-Deoxy-2'-fluoroinosine | C10H11FN4O4 | 80049-87-2 | Details |
| 4-(1H-Pyrazol-3-yl)phenol | C9H8N2O | 68535-53-5 | Details |
| GAA Blocking Peptide | Details |
| 2-(4-Bromophenyl)morpholine | C10H12BrNO | 83555-73-1 | Details |
| Methyl 6-Hydroxy-2,3-dihydrobenzofuran-2-carboxylate | C10H10O4 | 1803591-79-8 | Details |
| Coagulation Factor XIIIa (190-230) | C220H322N54O73 | 158455-48-2 | Details |
| Undecyl b-D-maltopyranoside | C23H44O11 | 253678-67-0 | Details |
| 4-Amino-1-(2-phenoxyethyl)pyrrolidin-2-one hydrochloride | C12H17ClN2O2 | 1354950-83-6 | Details |
| Kinase E19 antibody | Details |
| Sumanirole maleate | C15H17N3O5 | 179386-44-8 | Details |
| 2'[3']-O-Acetyl-N6-benzoyl-5'-O-DMT-adenosine 3'[2]-O-succinate triethylamine salt | Details |
| 2-(2-Chlorophenyl)-N-(3-hydroxypropyl)acetamide | C11H14ClNO2 | 1156897-71-0 | Details |
| 3-Formyl-N,N-dimethylbenzamide | C10H11NO2 | 126926-36-1 | Details |
| Palosuran hydrochloride | C25H31ClN4O2 | 2469274-58-4 | Details |
| 2-(Bromomethyl)-1,3-diethylbenzene | C11H15Br | 1247022-13-4 | Details |
| Ac-Leu-Glu-His-Asp-MCA | C33H41N7O11 | 292633-16-0 | Details |
| PNMAL1 antibody | Details |
| 3-(1,3-Dioxolan-2-yl)thiophene-2-carbaldehyde | C8H8O3S | 13250-83-4 | Details |
| Ethyl 2-(cyclobutylamino)acetate | C8H15NO2 | 742015-31-2 | Details |
| 1-(4-Bromo-2-chlorophenyl)-1H-1,2,3-triazole-4-carboxylic acid | C9H5BrClN3O2 | 1099026-08-0 | Details |
| 2,3,4,6-Tetra-O-acetyl-a-D-mannopyranosyl fluoride | C14H19FO9 | 2823-44-1 | Details |
| Cryptococcus neoformans antibody | Details |
| 6-Phenyl-1-[(pyridin-4-yl)methyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C19H14N4O2 | 869464-83-5 | Details |
| HMOX2 antibody | Details |
| 4-(4-Bromobutyl)morpholine Hydrobromide | C8H17Br2NO | 1803587-12-3 | Details |
| trans-4-(1-Pyrrolidinyl)tetrahydro-3-furanamine | C8H16N2O | 1212157-31-7 | Details |
| H-KRGIVEQCCTSICSLYQ-OH | Details |
| 6-Chloro-N-(2,5-difluorophenyl)pyridine-3-sulfonamide | C11H7ClF2N2O2S | 1040084-43-2 | Details |
| 3-Ethoxypropanimidamide hydrochloride | C5H13ClN2O | 1170847-92-3 | Details |
| {[4,5-Dimethoxy-2-(methylsulfanyl)phenyl]methyl}(methyl)amine | C11H17NO2S | 1333889-03-4 | Details |
| (3-Fluorocyclohexyl)methanamine hydrochloride | C7H15ClFN | 1374657-39-2 | Details |
| 10’-Apo-β-carotenal | C27H36O | 640-49-3 | Details |
| BIRC7 antibody | Details |
| 1-(2-Aminoethyl)-1,3-dihydro-2,1,3-benzothiadiazole-2,2-dione hydrochloride | C8H12ClN3O2S | 1607276-71-0 | Details |
| 4-(Chloromethyl)-2-(3,4-dimethoxyphenyl)-1,3-thiazole hydrochloride | C12H13Cl2NO2S | 1052537-37-7 | Details |
| DCN antibody | Details |
| CRTC1 antibody | Details |
| 2-((4-Phenoxyphenyl)amino)-1,3-thiazole-4-carboxylic acid | C16H12N2O3S | 1176721-85-9 | Details |
| (2R,3S)-3-Amino-2-hydroxy-4-phenylbutanoic acid | C10H13NO3 | 62023-63-6 | Details |
| 4-(1-Methylethyl)-2,6,7-trioxa-1-phosphabicyclo(2.2.2)octane-1-oxide | C7H13O4P | 51052-72-3 | Details |
| 4-Hydroxy-3-methyl-benzophenone | C14H12O2 | 5326-42-1 | Details |
| Goat anti Human Kappa Chain (Texas Red) | Details |
| 2-[(4-tert-Butylphenyl)sulfanyl]acetic Acid | C12H16O2S | 4365-63-3 | Details |
| 2-[2-Chloro-5-(trifluoromethyl)benzenesulfonamido]acetic acid | C9H7ClF3NO4S | 732291-51-9 | Details |
| 2-Fluoro-5-(piperidin-4-yloxy)pyridine hydrochloride | C10H14ClFN2O | 1803567-36-3 | Details |
| tert-Butyl 2-(2-cyclopropyl-2-oxoethyl)pyrrolidine-1-carboxylate | C14H23NO3 | 1499728-69-6 | Details |
| 2-Chloro-N-[4-(3-methylphenoxy)phenyl]acetamide | C15H14ClNO2 | 69838-52-4 | Details |
| 4-(Aminomethyl)-N,N,1,3-tetramethyl-1H-pyrazol-5-amine hydrochloride | 2402839-67-0 | Details |
| 3-Chloro-N-(cyclopropylmethyl)-4-methoxyaniline | C11H14ClNO | 1156170-95-4 | Details |
| 3-Methoxypyrazine-2-carboximidamide dihydrochloride | C6H8N4O.2ClH | 2361734-42-9 | Details |
| 1-Ethyl-6-methyl-1H-1,3-benzodiazole | C10H12N2 | 26530-88-1 | Details |
| [1-(4-Piperidin-1-ylphenyl)ethyl]amine dihydrochloride | C13H22Cl2N2 | 1215504-97-4 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||